The elusive BAP1 mutation in pediatric melanocytic tumors

Pediatr Dermatol. 2024 Sep-Oct;41(5):822-824. doi: 10.1111/pde.15705. Epub 2024 Jul 30.

Abstract

Cutaneous BAP1-inactivated melanocytomas (BIM) are melanocytic proliferations defined histopathologically by an epithelioid, predominantly dermal melanocytic proliferation with loss of BAP1, and have been largely characterized in adult patients but less well-described in pediatric cohorts. BIM share overlapping histological features with those seen in Spitz nevi; however, unlike Spitz nevi, the majority of BIM carry both BAP1 and BRAFV600E mutations. This study investigated the potential overlap of BIMs with pediatric Spitz nevi by performing immunohistochemical staining of BAP1 and BRAFV600E on pediatric melanocytic tumors with banal Spitz and dermal features. None of the stained tumors in our study exhibited the concurrent BAP1 loss and BRAFV600E positivity that are characteristic of adult BIM, suggesting that this is a low-frequency mutation among banal tumors in the pediatric population.

Keywords: BAP1 protein; BAP1‐inactivated melanocytoma; BAPoma; BRAF; Spitz nevus; dermal nevus; pediatric melanoma; uveal melanoma.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Melanoma / genetics
  • Melanoma / pathology
  • Mutation*
  • Nevus, Epithelioid and Spindle Cell* / genetics
  • Nevus, Epithelioid and Spindle Cell* / pathology
  • Proto-Oncogene Proteins B-raf / genetics
  • Skin Neoplasms* / genetics
  • Skin Neoplasms* / pathology
  • Tumor Suppressor Proteins* / genetics
  • Ubiquitin Thiolesterase* / genetics

Substances

  • BAP1 protein, human
  • Ubiquitin Thiolesterase
  • Tumor Suppressor Proteins
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf

Grants and funding